Injectable formulation of disodium 1-[2-(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate (PROLI/NO), an ultrafast nitric oxide donor prodrug

David J. Waterhouse, Larry K. Keefer(Unknown), George Grimes(National Institutes of Health Clinical Center), Michael L. Citro(Genesis Laboratories), Douglas Powell(Data Management Services (United States)), Xia Xu(Science Applications International Corporation (United States)), Gopal K. Potti(National Institutes of Health Clinical Center), Keith M. Davies(George Mason University), Joseph E. Saavedra(Genesis Laboratories)
Journal of Pharmaceutical Sciences
November 28, 2005
Cited by 15


Related Papers